Background: The natural course of persistent/recurrent differentiated thyroid cancer (DTC)
has not been fully elucidated. The purpose of this study was to assess the relative incidence …

Background We identified factors predictive of outcome for recurrent differentiated thyroid
carcinoma (DTC). Methods Fifty-seven patients with local (LR), regional (RRec), and/or …

Context Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …

Background: Trends in the epidemiological profiles of differentiated thyroid cancer (DTC)
have shifted the disease spectrum. This study aimed to evaluate the recurrence rates and …

Background: Despite the excellent prognosis of differentiated thyroid carcinoma (DTC),
recurrent and persistent disease remain major challenges. Emerging studies to differentiate …

The incidence rates of structural persistent disease (PD) and recurrent disease (RD) after
thyroidectomy, and their clinicoradiological (CT) characteristics, remain poorly understood …

Aim: We aimed to analyze the prognostic factors affecting disease-specific survival in
patients with recurrent and/or metastatic differentiated thyroid carcinoma. Methods: Seventy …

Objective To discuss the risk of recurrence in patients with differentiated thyroid cancer and
emphasize the importance of risk-group stratification. Methods Common risk factors …

Background: The primary goals of this interdisciplinary consensus statement are to define
the eligibility criteria for management of recurrent and persistent cervical nodal disease in …

Background The AMES (age, distant metastasis, tumor extent, and size), AGES (age, tumor
size, histologic grade, tumor extent, distant metastasis), and MACIS (distant metastasis, age …